Connect with us

business

Cost-Cutting in Cannabis Industry, and What It Means for You

Published

on


If we think back a few years to all the “green rush” headlines circulating about cannabis, it’s a little bit hard to wrap your head around where the industry is at today. Unfortunately, today’s cannabis industry is plagued with many struggles amid falling wholesale prices and plummeting sales at legal stores.

What’s more, it seems the pain is only beginning, and companies are trying to correct course by cutting costs in anyway possible. Often, that’s at the expense of employees who are laid off or get their salaries reduced, and consumers who are left with cheaply-made, overpriced products available at a decreasing number of retail stores.  

What’s going on the in the cannabis industry lately? 

Although legalization is overall a good thing (people getting arrested for cannabis possession is ridiculous, I think we can all agree to that), the bottom line is, the industry is not generating nearly as much revenue as anticipated, and businesses are struggling. Pretty much everyone in the supply chain including cultivators, extractors, dispensary owners, and even those operating ancillary businesses like software and technology are feeling the pain of this stressed market.  

But the problem is not demand, people are still buying weed in the same numbers, if not more so, than in years prior. There’s been a huge uptick in middle-aged to older Americans who use cannabis products as well. So it’s not that people are losing interest in weed, although the culture has changed dramatically, it’s because of numerous different elements that make it difficult for weed business to make a profit – mainly taxes and the still-thriving black market.  

Cannabis businesses are notoriously overtaxed. Then factor in the many other costs and fees associated with operating a weed business, and it translates to higher prices for consumers. Higher than what they would find from a street dealer or unlicensed (black-market) dispensary. And because these unregulated distributors have access to all the same products, sometimes better ones, than legal dispensaries, that makes for an extremely hostile and competitive environment for any trying to operate an above-board cannabis business.  

The are quite a few other issues with today’s cannabis market, such as oversupply of flower – to the point that growers are having trouble selling off much of their stock, difficulty advertising on prominent search engines and social media sites, problems finding property and real estate for their business endeavors, banking/financing struggles, and the list goes on.  

In response, big players in the industry are trying to cut costs in any way possible; from mass layoffs and salary cuts, to store closures, and even taking shortcuts on the production side of things. Summarized, the cannabis industry is not faring well at the moment, and these cost-cutting measures are likely to continue well into 2024. 

Through the first part of the COVID-19 pandemic, people were receiving government assistance and many were working remotely. Sales exploded. This environment fueled additional spending in the cannabis sector, according to Gullickson. Now, consumers are spending less to prepare for a possible recession. Combined with a lack of movement on SAFE Banking or any major federal reform, investors have taken notice. “Capital has gone by the wayside and businesses are having to course-correct,” Gullickson added. “Cannabis market numbers at the end of 2020 and the beginning of 2021 were inflated in many ways and valuations were astronomical.” 

Mass layoffs and salary cuts

Layoffs in the industry are widespread and not limited to any specific areas or sectors. Everyone is getting hit relatively hard. Several large, multistate operators including Curaleaf and Trulieve, as well as many smaller and ancillary companies. Additionally, a growing number of high-profile executives have been leaving the industry. “I don’t think layoffs have peaked. I think this will continue into 2024 for sure,” said Sara Gullickson, CEO and founder at The Cannabis Business Advisors, in an interview with MJBizDaily.  

Many companies are also resorting to reducing employee salaries in an effort to keep jobs but save money. This is a bit less widespread than the layoffs, but a growing issue, nonetheless.  

Over the past several months, layoffs and salary cuts have been reported by: 

  • Oregon-based cannabis retail technology firm Dutchie laid off over 10% of its workforce in two rounds of layoffs last June and November.  
  • Cannabis tech company WM Technology (operator of California-based Weedmaps) laid off over 25% of its workforce (or 175 employees) last year. A few of their top executives resigned as well: which laid off 175 employees, or 25% of its workforce, in November. CEO Chris Beals, Chief Operating Officer Juanjo Feijoo and Chief Technology Officer Justin Dean. Their stock also dropped over 80% in 2022.  
  • Massachusetts-based Curaleaf cut 220 employees in November and 50 in August. The company closed its Sacramento, California, facility. They also announced a 10% payroll reduction across the board.  
  • Seattle-based cannabis commerce platform Leafly Holdings laid off 56 employees in October, or 21% of its workforce. COO Sam Martin resigned from the company in December. 
  • Florida-based Trulieve cut roughly 36 employees in Pennsylvania in December, and an undisclosed number in Florida. 
  • New York-based cannabis wholesale platform Leaflink cut 80 jobs in December. 
  • Denver-based compliance software company Akerna terminated 56 positions in May. A 25% salary cut will also be implemented.  
  • Florida cannabis marketing technology company Springbig reduced its workforce by 23%, or 37 jobs, through “layoffs and attrition.” 
  • Green Leaf Medical, a subsidiary of New York-based MSO Columbia Care laid off 73 employees in Saxton, Pennsylvania, in February of this year.  


Store and facility closures  

Numerous dispensary chains, large and small, are closing their less profitable stores, leaving consumers with less options for legal pot purchases. In September of last year, Canopy Growth announced that it was planning to off many of its retail locations throughout Canada, including stores under the Tweed and Tokyo Smoke brand names.  

In a letter to shareholders, Zachary George, CEO of Sundial Growers, one of Canada’s largest operators of adult-use cannabis stores, announced a wave of potential closures. He warned the “trickle” of cannabis store closures could grow into a flood “with the toll likely closer to 1,000 than 100. Most retailers are struggling to be profitable, and we are starting to observe a trickle of closures on a weekly basis.” 

In January, Curaleaf officially stated that they would be closing all of their retail locations in California, Colorado, and Oregon as part of their “continued effort to streamline business operations.” They currently have only one store left in that region, which is on Fremont Street in Portland. All of their California and Colorado dispensaries and cultivation/production facilities have been shut down.  

In the Midwest, Michigan-based retailer Lume Cannabis closed 4 of its 30 stores in the state. This was shortly after they announced plans to have 100 stores in Michigan by 2025. In Michigan, like many other legal markets, oversaturation is a serious problem that has resulted in substantially lower product prices. The stores that were closed – in Bay City, Cheboygan, Christmas and Southfield – had experienced serious sales declines. 

Taking shortcuts 

Aside from disposing of employees to save money, many companies are taking some shortcuts on the production side of things to save money. Although it’s hard to get statistics on exactly how many products are poorly made, mislabeled, or contaminated, if you’re a regular visitor to dispensaries, and especially if you travel and go to different locations frequently, you know those number are quite high.  

Some of the product-related issues a consumer might experience include: 

  • Poorly produced products – this can be edibles with low-quality ingredients, poorly manufactured vape carts and disposables, glassware and other smoking devices that are defective or otherwise subpar, and the list goes on.  
  • Mislabeling and falsified lab reports – a lot of cannabis products on the shelves these days are mislabeled, so even when trying to shop smart, it can still be difficult for a consumer to know what they’re getting. A common tactic used by producers is to send in the best samples for batch testing, and use the labels for the rest of their products.   
  • Contaminated and diseased flower – pesticides, herbicides, and other environmental contaminants plague many weed crops. There has also been the ongoing issue of hop latent viroid, an infectious plant pathogen that has been found in up to 90% of commercial crops.  
  • Bad/cheap extractions – if you dab often, then you have more than likely experienced the butane taste associated with poor extractions. If it happens occasionally, that’s one thing, but I was experiencing it so often that I stopped smoking/dabbing concentrates entirely.  

Ancillary companies and the ‘trickle-down’ effect 

As you likely noticed in the layoffs section, it’s not just companies directly connected to cannabis products that are feeling the brunt – many ancillary companies are in trouble as well, particularly those in the software and technology sector. Leafly, Akerna, Leaflink and others are implementing many of the cost-cutting measures listed above.  

According to Gullickson, even though their services are specialized and needed by the broader cannabis industry, the problems facing cultivators and retailers are trickling down to non-plant-touching ancillary companies. “We’re seeing a trickle-down effect,” she wrote. “As capital and revenue declines on the plant-touching side, it strangles many of the ancillary businesses that rely on those operators for their customer base.” 

In Akerna’s case, the company laid off a large number of employees AND their executive team agreed to a 25% cut in compensation as part of company’s plan to “accelerate their path to profitability,” as stated in a recent press release. Earlier this year, Akerna also announced that they would be selling 365 Cannabis back to some of their previous investors, but they are selling it for much less than they purchased it for back in 2021.  

Final thoughts 

Welcome readers! Thanks for hanging out with us at Cannadelics.com; an independent publication that brings you new and ongoing stories in the cannabis and hallucinogen spaces. Come ’round regularly so you don’t miss out on anything; and subscribe to our Cannadelics Weekly Newsletter, to ensure you’re never late to get the news.



Source link

Continue Reading

business

Astronauts to Test Cannabis Growth in Outer Space

Published

on

By


NASA‘s recent collaboration with the International Space Research Consortium to launch a mission testing the cultivation of cannabis in the microgravity of space has stirred a whirlwind of interest and controversy across the globe. This initiative aims to unravel the mysteries of how low-gravity environments affect plant growth, with cannabis serving as the pioneering subject. According to Dr. Alfred Terra, the esteemed lead scientist spearheading the project, the conditions in space present an “unparalleled opportunity” to push the boundaries of our understanding of botany and its applications in medicine and agriculture beyond Earth’s confines.

This ambitious endeavor aims to shed light on the potential for utilizing space-based agriculture to support long-duration space missions and future colonization efforts on other planets. The choice of cannabis as a research subject is particularly intriguing due to its complex biochemical makeup and its increasing use in medicinal therapies on Earth. Insights gained from how cannabis adapts to space’s harsh environment could lead to breakthroughs in growing food and medicinal plants in extraterrestrial colonies.

Despite the scientific excitement surrounding the mission, the announcement has been met with its share of skepticism and criticism. Some members of the scientific community and the general public question the allocation of resources toward cannabis research in space, arguing that more pressing scientific and exploratory questions merit attention aboard the International Space Station (ISS). These critics call for a focus on projects that directly contribute to our understanding of space travel’s impacts on human physiology or further our knowledge of the cosmos.

However, the space agencies involved have been quick to highlight the broader implications of this research. They argue that studying cannabis growth in microgravity could offer invaluable insights into plant biology, stress responses, and the possibility of cultivating a variety of crops in space, which are crucial for the long-term sustainability of space exploration and eventual human settlement on other planetary bodies.

Amidst the debates over the mission’s merits and the speculation spurred by its announcement date—April 1st—lies a deeper curiosity about the future of space exploration and the role of innovative agricultural research in that journey. The timing has led some to question the announcement’s authenticity, pondering whether it could be an elaborate April Fool’s Day jest aimed at sparking discussion or simply a coincidence that has amplified the public’s fascination with the project.

Whether viewed as a bold step into the future of space agriculture or a controversial choice of research focus, the mission symbolizes a growing intersection between space exploration and the quest to understand and utilize biological processes in unprecedented environments. As the launch date approaches and preparations continue, the world watches, eager to see what insights this venture might unfold about cannabis, plant science, and the potential for life beyond Earth.

*** This article is an April Fool’s Day joke ***



Source link

Continue Reading

business

A Hiring Wave on the Horizon

Published

on

By


The U.S. cannabis industry is on the brink of a significant hiring wave in 2024, spurred by a 12% increase in legal sales in 2023, reaching $29 billion. This growth, alongside potential federal reclassification of cannabis, is expected to create up to 100,000 new jobs, particularly in the retail sector, where 93% of companies plan to expand their workforce. The Vangst 2024 Cannabis Salary Guide highlights an industry ready to bounce back from previous economic stagnation, with a strong emphasis on experience, adaptability, and cultural fit in prospective employees.

The cannabis sector is poised for a massive expansion in employment opportunities in 2024, following a year of economic challenges and layoffs. This optimistic forecast comes from Vangst’s latest industry salary guide, which anticipates a hiring boom driven by increased legal cannabis sales and the potential for federal rescheduling. The anticipated move to reclassify cannabis to Schedule III could significantly reduce tax burdens, increase company valuations, and attract more investors, according to Viridian Capital Advisors.

Retail cannabis companies are at the forefront of this hiring surge, with nearly all surveyed indicating plans to bolster their teams in response to growing demand and market expansion. The focus is not just on filling positions but on finding candidates who can navigate the evolving legal and market landscape, prioritize cultural fit, and possess strong communication skills over traditional qualifications.

Salaries in the cannabis industry have also seen an uptick, with top-end wages growing by 4.7%, outpacing the national non-cannabis average. However, the sector still trails behind others in offering comprehensive benefits packages, a gap that affects employee satisfaction and retention. The demand for health insurance and better work-life balance is clear among job seekers in the cannabis space.

Diversity and inclusion are gaining traction within cannabis company hiring practices, with a significant portion of companies implementing strategies to create a more inclusive workforce. The industry’s employment of veterans and individuals with disabilities highlights its diverse nature, but there remains room for improvement.

Why It Matters: This hiring wave marks a pivotal moment for the cannabis industry, signaling a shift towards recovery and growth after a period of stagnation. It underscores the industry’s resilience and its potential to contribute significantly to the economy through job creation and increased sales.

Potential Implications: The anticipated hiring boom in the cannabis industry could lead to wider acceptance and normalization of cannabis use, further influencing policy changes and societal attitudes. Additionally, the focus on diversity and inclusion could set a precedent for other sectors, promoting a more inclusive workforce across industries.

Source: Green Market Report



Source link

Continue Reading

business

86% of Californians Support Legal Cannabis Markets

Published

on

By


A recent survey conducted by the California Department of Cannabis Control (DCC) and FM3 Research reveals that a significant majority of Californians, 86%, believe it’s important to purchase cannabis from legal markets. The survey also indicates growing support for Proposition 64 and highlights the need for consumer education on legal cannabis procurement.

California, a pioneer in legalizing medical cannabis in 1996 and later adult-use cannabis in 2016, has developed into the world’s largest cannabis market. The DCC’s Real California Cannabis Campaign, aimed at guiding consumers to licensed dispensaries, commissioned FM3 Research to survey over 1,000 California adults to gauge their attitudes towards the state’s cannabis market. Key findings include:

  • 62% view Proposition 64 positively, suggesting increased support for cannabis reform.
  • 86% of respondents stress the importance of buying cannabis from legal sources.
  • 72% feel consumers should ensure they’re purchasing from licensed retailers.
  • Despite the legal market’s size, illegal sales remain prevalent, with two-thirds of cannabis sales in 2022 coming from the illicit market.
  • The California Unified Cannabis Enforcement Taskforce (UCETF) reported significant seizures in 2023, including over $312 million in illegal cannabis and 119 firearms, showcasing efforts to combat illegal operations.
  • The survey uncovered education gaps, with 85% of respondents in areas where retail cannabis is banned either misinformed or unaware of local cannabis laws.
  • Opinions on identifying licensed retailers were divided, with 44% finding it easy and 42% finding it challenging.

Why It Matters: This survey underscores the growing acceptance of legal cannabis markets among Californians and the critical role of consumer education in supporting legal operations. It highlights the ongoing battle against illicit sales and the importance of regulatory efforts to ensure a safe, legal cannabis market.

Potential Implications: The findings could influence future cannabis policies in California, emphasizing the need for public education campaigns and stricter enforcement against illegal operations. It also suggests a potential shift in consumer behavior towards supporting legal cannabis sources, which could further legitimize and stabilize the legal market.

Source: High Times



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media